Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)

NCT01942135 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

521

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Palbociclib
DRUG: Fulvestrant
DRUG: Placebo
DRUG: Fulvestrant

Sponsor

Pfizer

Collaborators

[object Object]